Summary
Neoadjuvant therapy is therapy administered before surgical intervention and while the tumor remains in the breast. It may be given to treat large, locally advanced tumors, with the aim of shrinking them and thus making their surgical excision either simply possible or less radical. Most neoadjuvant therapy is chemotherapy, but adjuvant endocrine therapy is increasingly used in hormone-sensitive tumors; for example, those responsive to tamoxifen. Repeat biopsies aimed at assessing response to treatment—for example, by examining estrogen receptor status or markers of proliferation in tumor tissue—may be taken during the course of adjuvant therapy. In this chapter, the essential protocols associated with designing neoadjuvant trials are described, methods of assessing response to neoadjuvant therapy are detailed, and various approaches to collecting appropriate clinical samples and their assessment are presented.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anderson, T., Hawkins, R. A., et al. (1999) Neoadjuvant endocrine treatment: the Edinburgh experience, in ESO Scientific Updates, Volume 4. Primary Medical Therapy for Breast Cancer (Howell, A., Dowsett, M., eds.). Elsevier, Amsterdam, The Netherlands, pp. 1–11.
Mustacchi, G., Milani, S., Pluchinotta, A., et al. (1994)Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer. The GRETA trial. Anticancer Res. 14, 2197–2200.
Gazet, J. C., Ford, H. T., Coombes, R. C., et al. (1994) Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer. Eur. J. Surg. Oncol. 20, 207–214.
Van Dalsen, A. D. and De Vries, J. (1995) Treatment of breast cancer in elderly patients. J. Surg. Oncol. 60, 80–82.
Bates, T., Riley, D. L., Houghton, J., et al. (1991) Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. Br. J. Surg. 78, 591–594.
Anderson, E. D. C., Forrest, A. P. M., Levack, P. A. et al. (1989) Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer. Br. J. Cancer 60, 223–226.
Dixon, J. M. (2001) Neoadjuvant endocrine therapy, in Aromatase Inhibition and Breast Cancer (Miller, W. R., Santen, R. J., eds.) Marcel Dekker, Basel, Switzerland.
Keen, J. C., Dixon, J. M., Miller, E. P., et al. (1997) The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer. Breast Cancer Res. Treat. 44, 123–133.
Dixon, J. M., Love, C. D. B., Tucker, S., et al. (1997) Letrozole as primary medical therapy for locally advanced and large operable breast cancer. Breast Cancer Res. Treat. 46(Suppl), 54.
Kenny, F. S., Robertson, J. F. R., Ellis, I. O., et al. (1999) Primary tamoxifen versus mastectomy and adjuvant tamoxifen in fit elderly patients with operable breast cancer of high ER content. Breast 8, 216.
Forouhi P., Walsh, J. S., Anderson, T. J., and Chetty, U. (1994) Ultrasound as a method of measuring breast tumour size and monitoring response to primary systemic therapy. Br. J. Surgery 81, 223–225.
Dixon, J. M., Renshaw, L., Bellany, C., et al. (1999) Efficacy of anastrozole as neoadjuvant therapy in postmenopausal women with large operable breast cancers: reductions in tumor volume. Breast 8, 215.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Murray, J., Miller, W.R., Dixon, J.M. (2006). Neoadjuvant Endocrine Therapy Models. In: Brooks, S.A., Harris, A. (eds) Breast Cancer Research Protocols. Methods in Molecular Medicine, vol 120. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-969-9:489
Download citation
DOI: https://doi.org/10.1385/1-59259-969-9:489
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-191-2
Online ISBN: 978-1-59259-969-1
eBook Packages: Springer Protocols